Tomasz Grabowski

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Diabetic Nephropathy

Anaerobic Digestion

Top Venues

Cancer chemotherapy and pharmacology

Drug and chemical toxicology

Pharmacological reports : PR

Journal of veterinary science

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna Stanisławiak-Rudowicz, Agnieszka Karbownik, Danuta Szkutnik-Fiedler, Filip Otto, Tomasz Grabowski, Anna Wolc, Edmund Grześkowiak, Edyta Szałek
Bidirectional pharmacokinetic drug interactions between olaparib and metformin. Cancer chemotherapy and pharmacology (2023)
Malgorzata Tyszka-Czochara, Anna Adach, Tomasz Grabowski, Paweł Konieczny, Paweł Pasko, Joanna Ortyl, Tomasz Świergosz, Marcin Majka
Selective Cytotoxicity of Complexes with N,N,N-Donor Dipodal Ligand in Tumor Cells. International journal of molecular sciences 22 (4) (2021)
Tomasz Grabowski, Artur Burmańczuk, Rafał Derlacz, Tadeusz Stefaniak, Anna Rząsa, Jacek Borkowski
Ustekinumab pharmacokinetics after subcutaneous administration in swine model. Journal of veterinary science 22 (5) (2021)
Agnieszka Karbownik, Anna Stachowiak, Hanna Urjasz, Katarzyna Sobańska, Agnieszka Szczecińska, Tomasz Grabowski, Joanna Stanisławiak-Rudowicz, Anna Wolc, Edmund Grześkowiak, Edyta Szałek
The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats. Pharmacological reports : PR 72 (1) (2020)
Tomasz Grabowski, Joannes A A Reijers, Artur Burmańczuk, Anna Chełmońska-Soyta
Fluctuations in Pharmacokinetics Profiles of Monoclonal Antibodies. European journal of drug metabolism and pharmacokinetics 44 (5) (2020)
Agnieszka Karbownik, Katarzyna Sobańska, Tomasz Grabowski, Joanna Stanisławiak-Rudowicz, Anna Wolc, Edmund Grześkowiak, Edyta Szałek
In vivo assessment of the drug interaction between sorafenib and paracetamol in rats. Cancer chemotherapy and pharmacology 85 (6) (2020)
Tomasz Grabowski, Jost Leuschner, Shayne Gad
4-Week toxicity study of biosimilar natalizumab in comparison to Tysabri® by repeated intravenous infusion to cynomolgus monkeys. Drug and chemical toxicology (2020)